ARCHIVES

Capitated Oncology Becomes Marketplace Reality Wit Plan By Companies

This article is from The Cancer Letter archive.

Vol. 20 No. 02 | January 14, 1994

Download PDF Visit The Full Archive

Related Articles

NCI Offers 200 Cell Lines to Scientist

May 6, 1983

Love, Avon Foundations Recruit Women For Research.

October 3, 2008

Avastin Phase III Trial Meets Endpoint: PFS in Platinum-Sensitive Ovarian Cancer

February 25, 2011

Tempero, Johnson Take ASCO Offices

June 6, 2003

In Brief: Megastrol Acetate Still Under FDA Review; Mays Hired For NCI’s Technology Office

July 20, 1990

DCPC Board Approves Concepts for $28.5 Million Polyp Trial, Other Nutrition Related Studies

May 19, 1989